Imaging Technology News - ITN

Serial non-contrast axial chest CTs of three study participants with prior COVID-19 pneumonia.
News | Coronavirus (COVID-19)
Lung Damage May Persist Long After COVID-19 Pneumonia

March 29, 2022 — Some people recovering from COVID-19 pneumonia have CT evidence of damage to their lungs that persists ...

Time March 29, 2022
arrow
“The Fundamental Flaws of the Canadian National Breast Screening Study (CNBSS) Trials: A Scientific Review,” authored by Seely, et al and published on March 29, 2022 in the Journal of Breast Imaging, reinforces criticism directed towards the CNBSS trials.
News | Breast Imaging
First-Hand Accounts in New Paper Cement the Flaws of Decades Old Study

March 29, 2022 — “The Fundamental Flaws of the Canadian National Breast Screening Study (CNBSS) Trials: A Scientific ...

Time March 29, 2022
arrow
GE Healthcare announced the first patient dosed in the Phase III clinical trial for a Positron Emission Tomography (PET) radiopharmaceutical imaging agent which aims to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care. 
News | PET Imaging
GE Healthcare Announces First Patient Dosed in Phase III Clinical Trial for New Dopamine Transporter Imaging Radiopharmaceutical

March 29, 2022 — GE Healthcare announced the first patient dosed in the Phase III clinical trial for a Positron Emission ...

Time March 29, 2022
arrow
HIMSS22 hosted nearly 29,000 attendees on-site and on HIMSS22 Digital who attended for the education, innovation and collaboration they need to reimagine health and wellness for everyone, everywhere. 
Gallery | HIMSS | By Melinda Taschetta-Millane
Photo Gallery of Information Technology Showcased at HIMSS22

This gallery includes photos of information technology from across the expo floor at the Healthcare Information and ...

Time March 28, 2022
arrow
P-Cure Ltd., the provider of the most compact 360° gantry-less adaptive proton therapy system, announced today the opening of a clinical research and training site within its headquarters in Israel.
News | Proton Therapy
P-Cure Demonstrates the Proton Therapy Equipment Can Now Be Installed In Existing Radiation Therapy Rooms

March 28, 2022 — P-Cure Ltd., the provider of the most compact 360° gantry-less adaptive proton therapy system ...

Time March 28, 2022
arrow
Representative transvaginal US images of classic lesions; color Doppler blood flow with color bar signifies direction of flow. (A) Transverse color Doppler image of right adnexa depicts an anechoic cyst with no internal elements or Doppler flow, compatible with a simple cyst. (B) Transverse color Doppler image of left adnexa depicts a cystic lesion with retractile clot and no Doppler flow, compatible with a hemorrhagic cyst. (C) Sagittal gray-scale image of left adnexa depicts a cystic lesion with homogeneo
News | Ultrasound Imaging
RSNA: Researchers Use Ultrasound to Predict Ovarian Cancer

March 28, 2022 — The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help ...

Time March 28, 2022
arrow
Selection of mammographic mediolateral oblique views of breasts with different breast density from women between 51 and 68 years of age.
News | Breast Density
AI Provides Accurate Breast Density Classification

March 28, 2022 — An artificial intelligence (AI) tool can accurately and consistently classify breast density on ...

Time March 28, 2022
arrow
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports Advanced Accelerator Applications, a Novartis company, as a long-term supplier for the medical radioisotope component of the newly U.S. Food and Drug Administration (FDA) approved radiotherapeutic, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treat
News | Prostate Cancer
ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer

March 28, 2022 — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports ...

Time March 28, 2022
arrow
T2w images with overlays of lesion boundaries, DWI-derived ADC, DCE-derived 𝐾𝑡𝑟𝑎𝑛𝑠, and CDI𝑠 for six patient cases. (a, b) Two patients with csPCa in the PZ. (c, d) Two patients with csPCa in the TZ. (e) A patient with csPCa in the PZ and insPCa in the TZ. (f) A patient with csPCa in the AS and insPCa in the PZ.
News | Magnetic Resonance Imaging (MRI)
MRI Innovation Makes Cancerous Tissue Light Up and Easier to See

March 28, 2022 — A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could ...

Time March 28, 2022
arrow
76-Year-Old Patient, Not on Antithrombotic Therapy, Presenting to ED After Ground-Level Fall (Glasgow Coma Scale of 15)
News | Computed Tomography (CT)
Antithrombotic Therapy Unassociated With Intracranial Hemorrhage After Fall

March 25, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), antithrombotic therapy was not linked to ...

Time March 25, 2022
arrow
The Abbreviated MR collection is designed to enhance a learner’s competence related to the utility of abbreviated breast MR, how to implement such a program, and the importance of performance metrics.
News | Breast Imaging
SBI Offers Symposium Collection Lecture Series

March 25, 2022 — SBI presents the Symposium Collection Series, a curation of lectures from the Society’s recent annual ...

Time March 25, 2022
arrow
Royal Philips, a global leader in health technology, and NHS National Services Scotland, a non-departmental public body that provides advice and services to National Health Service (NHS) Scotland, today revealed the impact of the COVID-19 pandemic on the Scottish Breast Screening Program (SBSP), and the measures taken to deal with the backlog of delayed appointments. 
News | PACS
Philips PACS interoperability Helps Scotland’s National Health Service Deliver Leading Breast Cancer Screening

March 25, 2022 — Royal Philips, a global leader in health technology, and NHS National Services Scotland, a non ...

Time March 25, 2022
arrow
The solution will enable pathologists to review and collaborate around cases in a way that is not possible with microscopes. This will reduce variation and increase efficiency in primary diagnostics, thereby improving cancer care.
News | Digital Pathology
Dutch University Medical Center Orders Sectra’s Digital Pathology Solution for Full-scale Primary Diagnostics

March 25, 2022 — International medical imaging IT and cybersecurity company Sectra has signed a digital pathology ...

Time March 25, 2022
arrow
Proscia, a leader in digital and computational pathology solutions, announced a multi-year OEM agreement with Siemens Healthineers. Under the agreement, Siemens Healthineers will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq Dx platform.
News | Digital Pathology
Proscia and Siemens Healthineers Ink Agreement to Expand Global Reach of Digital Pathology

March 25, 2022 — Proscia, a leader in digital and computational pathology solutions, announced a multi-year OEM ...

Time March 25, 2022
arrow
Royal Philips announced the expansion of its medical device cybersecurity services portfolio at HIMSS22. Philips is introducing Secure Remote Access Management Service [1], leveraging the broad set of security capabilities enabled by the integration of SecureLink’s critical access management and governance technology with Philips Remote Services’ secure connectivity framework for technical and clinical support.
News | Cybersecurity
Philips Expands its Cybersecurity Services Portfolio for Healthcare Providers

March 24, 2022 — Royal Philips announced the expansion of its medical device cybersecurity services portfolio at HIMSS22 ...

Time March 24, 2022
arrow
“To bring innovation and the agile approaches of smaller [information technology] companies to healthcare, you need to hide the complexities of the healthcare stack,” says Dr. Felix Nensa (top). “Edison Digital Health Platform does exactly that.” Image credits: Dr. Felix Nensa, GE Healthcare
News | Enterprise Imaging
GE Healthcare Developing a Digital Health Platform to Help Providers Accelerate Digital Transformation

March 24, 2022 — At HIMSS22, GE Healthcare announced its intention to introduce Edison Digital Health Platform, a vendor ...

Time March 24, 2022
arrow
At the annual meeting of the Healthcare Information and Management Systems Society (HIMSS), Konica Minolta Healthcare Americas, Inc. highlighted new features of the Exa Platform that automate common clinical and administrative tasks, enabling radiology departments and practices to enhance staff productivity, improve reimbursement and capture non-covered costs.
News | PACS
Konica Minolta Healthcare Highlights Automated Features in Exa Platform at HIMSS22

March 24, 2022 — At the annual meeting of the Healthcare Information and Management Systems Society (HIMSS), Konica ...

Time March 24, 2022
arrow
GE Healthcare unveiled a major digital update for Vscan Air, its cutting-edge, wireless handheld pocket-sized ultrasound device that provides crystal clear image quality, whole-body scanning capabilities, and intuitive software - all in the palm of clinicians’ hands. 
News | Ultrasound Imaging
GE Healthcare Advances Vscan Air Handheld Wireless Ultrasound

March 24, 2022 — GE Healthcare unveiled a major digital update for Vscan Air, its cutting-edge, wireless handheld pocket ...

Time March 24, 2022
arrow
Royal Philips announced its latest introductions in analytics and interoperability solutions at the HIMSS22 Global Health Conference & Exhibition. Philips HealthSuite Interoperability is a fully integrated cloud-enabled Health IT platform to meet diverse workflow needs across the imaging enterprise. 
News | Enterprise Imaging
Philips Introduces Cloud-enabled Enterprise Imaging Informatics and Analytics Solutions at HIMSS22

March 24, 2022 — Royal Philips announced its latest introductions in analytics and interoperability solutions at the ...

Time March 24, 2022
arrow
With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical therapy to treat metastatic castration-resistant prostate cancer (mCRPC)—the Society of Nuclear Medicine and Molecular Imaging (SNMMI) celebrates one of the greatest success stories in nuclear medicine history.
News | Prostate Cancer
SNMMI Applauds FDA Approval of New Metastatic Prostate Cancer Treatment

March 23, 2022 — With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical ...

Time March 23, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now